174 related articles for article (PubMed ID: 17230510)
41. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
[TBL] [Abstract][Full Text] [Related]
42. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
[TBL] [Abstract][Full Text] [Related]
43. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
44. Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients.
Shin BY; Chen H; Rozek LS; Paxton L; Peel DJ; Anton-Culver H; Rennert G; Mutch DG; Goodfellow PJ; Gruber SB; Lipkin SM
Dis Colon Rectum; 2005 Sep; 48(9):1723-7. PubMed ID: 15991064
[TBL] [Abstract][Full Text] [Related]
45. Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer.
McCourt CK; Mutch DG; Gibb RK; Rader JS; Goodfellow PJ; Trinkaus K; Powell MA
Gynecol Oncol; 2007 Mar; 104(3):535-9. PubMed ID: 17109938
[TBL] [Abstract][Full Text] [Related]
46. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
[TBL] [Abstract][Full Text] [Related]
47. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis.
Capel E; Fléjou JF; Hamelin R
Oncogene; 2007 Nov; 26(54):7596-600. PubMed ID: 17546041
[TBL] [Abstract][Full Text] [Related]
48. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.
Perera S; Mrkonjic M; Rawson JB; Bapat B
Oncol Rep; 2011 Mar; 25(3):809-15. PubMed ID: 21206982
[TBL] [Abstract][Full Text] [Related]
49. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.
Xiong Y; Dowdy SC; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2006 Oct; 103(1):321-8. PubMed ID: 16701802
[TBL] [Abstract][Full Text] [Related]
50. Causes and consequences of microsatellite instability in endometrial carcinoma.
Gurin CC; Federici MG; Kang L; Boyd J
Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
[TBL] [Abstract][Full Text] [Related]
51. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
[TBL] [Abstract][Full Text] [Related]
52. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
[TBL] [Abstract][Full Text] [Related]
53. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes.
Woods MO; Hyde AJ; Curtis FK; Stuckless S; Green JS; Pollett AF; Robb JD; Green RC; Croitoru ME; Careen A; Chaulk JA; Jegathesan J; McLaughlin JR; Gallinger SS; Younghusband HB; Bapat BV; Parfrey PS
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6853-61. PubMed ID: 16203774
[TBL] [Abstract][Full Text] [Related]
54. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.
Allan JM; Shorto J; Adlard J; Bury J; Coggins R; George R; Katory M; Quirke P; Richman S; Scott D; Scott K; Seymour M; Travis LB; Worrillow LJ; Bishop DT; Cox A; ;
Int J Cancer; 2008 Nov; 123(10):2456-9. PubMed ID: 18712731
[TBL] [Abstract][Full Text] [Related]
55. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
56. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
57. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry.
Ward RL; Dobbins T; Lindor NM; Rapkins RW; Hitchins MP
Genet Med; 2013 Jan; 15(1):25-35. PubMed ID: 22878509
[TBL] [Abstract][Full Text] [Related]
58. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.
Iacopetta B; Grieu F; Li W; Ruszkiewicz A; Caruso M; Moore J; Watanabe G; Kawakami K
Int J Cancer; 2006 Nov; 119(10):2272-8. PubMed ID: 16981189
[TBL] [Abstract][Full Text] [Related]
59. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.
Lin JC; Jeong S; Liang G; Takai D; Fatemi M; Tsai YC; Egger G; Gal-Yam EN; Jones PA
Cancer Cell; 2007 Nov; 12(5):432-44. PubMed ID: 17996647
[TBL] [Abstract][Full Text] [Related]
60. Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis.
Chen H; Shen Z; Hu Y; Xiao Q; Bei D; Shen X; Ding K
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2147-58. PubMed ID: 25986311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
